N/A
N=57
Magnetic Resonance Imaging (MRI) Brachytherapy Applicator Study
Cervical Cancer
Bottom Line
View on ClinicalTrials.gov: NCT01706705 ↗Enrolled (actual)
57
Serious AEs
0.0%
Results posted
Feb 2022
Primary outcome: Primary: Number of Participants With Improved Image Quality in the Shifted Position — 0; 15 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Intracavitary Applicator Placement (Device); Computed Tomography (CT) (Other); Magnetic Resonance Imaging (MRI) (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- Female
- Sponsor
- M.D. Anderson Cancer Center
- Primary completion
- Apr 2018
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Improved Image Quality in the Shifted Position |
0; 15 | — |
| SECONDARY Number of Participants With High Quality Images With the Adaptive Applicator in the Shifted or Standard Position |
0; 15 | — |
Summary
The goal of this clinical research study is to learn if computed tomography (CT) and magnetic resonance imaging (MRI) images can better help to plan internal radiation treatment.
Eligibility Criteria
Inclusion Criteria
- Women with stage greater than or equal to IB2 cervical cancer treated with definitive chemoradiation or radiation therapy who require intracavitary brachytherapy.
Exclusion Criteria
- Patient or tumor anatomy that requires use of a non-MRI-compatible applicator.
- Patients who require interstitial brachytherapy.
- Patients whose treating physician feels that they require additional 3D imaging at the time of implant based on physical exam or initial findings.
- Patients with implantable cardioverter-defibrillator, pacemaker or other implanted device, which precludes MRI acquisition.
Data sourced from ClinicalTrials.gov (NCT01706705). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.